| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a method for differentiating acute myeloid leukemia (de novo AML) from a leukemic myelodysplastic syndrome (MDS) by certainly detecting the MDS or the leukemic MDS difficult to be certainly detected by various conventional inspection means. <P>SOLUTION: MDS or leucomic MDS a diagnosed by detecting the presence of CD45 negative blast cells being a cell group specific to MDS to be identified as de novo AML. The cell group specific to MDS is the CD45 negative blast cells negative in CD45 and characterized in that the positive ratio of CD13 and CD33 is clearly lowered as compared with the CD45 positive mycloblast group in the same specimen. <P>COPYRIGHT: (C)2005,JPO&NCIPI</p> |
